October 13, 2026

Privia Health Group, Inc. (PRVA) Investor Outlook: 46.72% Potential Upside Ignites Interest

Privia Health Group, Inc. (NASDAQ: PRVA), a key player in the healthcare sector specializing in health information services, is attracting considerable attention from investors. With its market cap standing at..

Warby Parker Inc. (WRBY) Stock Analysis: Eyeing a 17.2% Potential Upside with Strong Buy Ratings

Warby Parker Inc. (WRBY), renowned for transforming the eyewear industry with its innovative retail and e-commerce platform, is garnering attention in the investment community. With its headquarters based in New..

Disc Medicine, Inc. (IRON) Stock Analysis: Exploring a 70.58% Upside Potential

Disc Medicine, Inc. (NASDAQ: IRON), a clinical-stage biopharmaceutical company specializing in hematologic diseases, is drawing significant attention from investors, and for good reason. With a market capitalization of $2.32 billion,..

LifeStance Health Group, Inc. (LFST) Investor Outlook: Exploring a 15% Upside Potential Amid a Growing Mental Health Demand

LifeStance Health Group, Inc. (NASDAQ: LFST) is a prominent player in the healthcare sector, specifically within the medical care facilities industry, with a focus on providing comprehensive outpatient mental health..

Enovis Corporation (ENOV) Investor Outlook: Nearly 98% Potential Upside Amid Robust Buy Ratings

Enovis Corporation (NYSE: ENOV) has been capturing the attention of investors with its substantial growth potential and strong analyst support. With a market capitalization of $1.05 billion, this U.S.-based healthcare..

Concentra Group Holdings (CON): Investor Outlook Reveals 9.22% Upside Potential in Healthcare Sector

For investors seeking opportunities in the healthcare sector, Concentra Group Holdings Parent, Inc. (NASDAQ: CON) presents an intriguing prospect. As a prominent player in the medical care facilities industry, Concentra..

CONMED Corporation (CNMD) Stock Analysis: Navigating Growth with a Stable Forward P/E of 9.49

CONMED Corporation (NASDAQ: CNMD), a longstanding player in the healthcare sector, specializes in medical devices aimed at enhancing surgical procedures. With a market capitalization of $1.36 billion, this Largo, Florida-based..

Organon & Co. (OGN) Stock Analysis: Weighing the Prospects Amidst a Potential -18.30% Downside

For investors with an eye on the healthcare sector, Organon & Co. (NYSE: OGN) presents a unique blend of opportunities and challenges. As a prominent player in the drug manufacturing..

SS Innovations International (SSII): Exploring a Potential 174% Upside in the Healthcare Sector

SS Innovations International, Inc. (SSII) is carving out a niche in the burgeoning field of surgical robotics, a segment within healthcare that is ripe with innovation and growth potential. Headquartered..

Sotera Health Company (SHC) Stock Analysis: Healthcare Innovator with 25% Upside Potential

Sotera Health Company (SHC) is making waves in the healthcare sector, offering sterilization solutions and comprehensive lab testing services worldwide. With a market capitalization of $5.18 billion, this U.S.-based company..

Protagonist Therapeutics, Inc. (PTGX) Stock Report: Analyzing a Potential 23% Upside with Strong Buy Ratings

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) has emerged as a noteworthy player in the biotechnology sector, captivating investor interest with its promising portfolio of innovative therapeutics. Headquartered in Newark, California, this..

Alphatec Holdings, Inc. (ATEC) Stock Analysis: A Promising 40% Upside in the Medical Device Sector

Alphatec Holdings, Inc. (NASDAQ: ATEC), a prominent player in the healthcare sector’s medical device industry, offers investors a compelling opportunity with a potential upside of 40.32%. With a market capitalization..

PGIM Securitized Income ETF (PINC): Performance Highlights and Market Position

For investors navigating the ever-evolving landscape of exchange-traded funds (ETFs), the PGIM Securitized Income ETF (NYSEARCA: PINC) presents a unique investment proposition. With a market capitalization of $4.06 billion and..

Addus HomeCare Corporation (ADUS) Stock Analysis: Exploring a 16% Potential Upside in Healthcare Investment

Addus HomeCare Corporation (NASDAQ: ADUS) is carving a niche in the healthcare sector with its comprehensive services, catering primarily to the needs of the elderly and chronically ill. With a..

PROCEPT BioRobotics (PRCT) Investor Outlook: Evaluating a 14% Upside with Revolutionary Innovations in Urology

In the ever-evolving landscape of healthcare, PROCEPT BioRobotics Corporation (NASDAQ: PRCT) emerges as a pioneering force, leveraging cutting-edge technology to transform urology. Headquartered in San Jose, California, PROCEPT BioRobotics is..

Supernus Pharmaceuticals, Inc. (SUPN) Investor Outlook: Exploring a Potential 44% Upside

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) is making waves in the healthcare sector, particularly within the niche of specialty and generic drug manufacturing. With a market capitalization of $2.49 billion, the..

Crinetics Pharmaceuticals, Inc. (CRNX) Stock Analysis: A Biotech Powerhouse with Astonishing 2,336% Revenue Growth Yet Faces Profitability Challenges

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX), a prominent player in the biotechnology sector, has been making waves with its impressive revenue growth figures. The San Diego-based clinical-stage pharmaceutical company is dedicated..

QuidelOrtho Corporation (QDEL) Stock Analysis: Navigating a Potential 10.69% Upside in the Medical Devices Sector

QuidelOrtho Corporation (NASDAQ: QDEL), a notable player in the healthcare sector, specifically within the medical devices industry, presents a unique investment opportunity with a potential upside of 10.69%. With its..

Kiniksa Pharmaceuticals (KNSA) Stock Analysis: Unveiling a 23.67% Upside with Robust Revenue Growth

Kiniksa Pharmaceuticals International, plc (NASDAQ: KNSA) is making waves in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. Based in the United Kingdom, this biopharmaceutical company..

GeneDx Holdings Corp. (WGS) Stock Analysis: Exploring a 46.51% Potential Upside

GeneDx Holdings Corp. (NASDAQ: WGS) is garnering attention in the healthcare sector, particularly within the diagnostics and research industry. Known for its pioneering work in genetic testing services, GeneDx focuses..

Search

Funds

October 13, 2026

Search

Funds

October 13, 2026

FTSE 100

Funds